DEFINIUM
LIVE

Serial Number

99632097

Owner

Definium Therapeutics US, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Feb 3, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DEFINIUM Trademark

Serial Number: 99632097

DEFINIUM is a trademark filed by Definium Therapeutics US, Inc. on February 3, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Definium Therapeutics US, Inc. (8 trademarks)

One World Trade Center, Suite 8500
New York, NY 10007

Entity Type: 03

Trademark Details

Filing Date

February 3, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of substance-use and addictive disorders

Drug discovery services; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the fields of psychiatry, neurology, and addiction medicine; medical and scientific research, namely, conducting clinical trials for others in the field of psychedelic-based therapeutics

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 3, 2026 MAFR
NEW APPLICATION ENTERED
Feb 3, 2026 NWAP